187 related articles for article (PubMed ID: 12390336)
21. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter.
Celani MF
Exp Clin Endocrinol; 1993; 101(5):326-32. PubMed ID: 8299711
[TBL] [Abstract][Full Text] [Related]
22. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
[TBL] [Abstract][Full Text] [Related]
23. Thyroid hormone levels affected by time of blood sampling in thyroxine-treated patients.
Ain KB; Pucino F; Shiver TM; Banks SM
Thyroid; 1993; 3(2):81-5. PubMed ID: 8369656
[TBL] [Abstract][Full Text] [Related]
24. Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy.
Puzziello A; Carrano M; Angrisani E; Marotta V; Faggiano A; Zeppa P; Vitale M
J Endocrinol Invest; 2014 Dec; 37(12):1181-6. PubMed ID: 25008459
[TBL] [Abstract][Full Text] [Related]
25. Levothyroxine suppression of thyroglobulin in patients with differentiated thyroid carcinoma.
Wang PW; Wang ST; Liu RT; Chien WY; Tung SC; Lu YC; Chen HY; Lee CH
J Clin Endocrinol Metab; 1999 Dec; 84(12):4549-53. PubMed ID: 10599717
[TBL] [Abstract][Full Text] [Related]
26. Short term effects of levothyroxine treatment in thyroid multinodular disease.
Cesareo R; Iozzino M; Isgrò MA; Annunziata F; Di Stasio E
Endocr J; 2010; 57(9):803-9. PubMed ID: 20683172
[TBL] [Abstract][Full Text] [Related]
27. Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: a randomized, placebo-controlled trial.
Grussendorf M; Reiners C; Paschke R; Wegscheider K;
J Clin Endocrinol Metab; 2011 Sep; 96(9):2786-95. PubMed ID: 21715542
[TBL] [Abstract][Full Text] [Related]
28. Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules.
Papini E; Petrucci L; Guglielmi R; Panunzi C; Rinaldi R; Bacci V; Crescenzi A; Nardi F; Fabbrini R; Pacella CM
J Clin Endocrinol Metab; 1998 Mar; 83(3):780-3. PubMed ID: 9506726
[TBL] [Abstract][Full Text] [Related]
29. Inappropriate Suppression of Thyrotropin Concentrations in Young Patients with Thyroid Nodules Including Thyroid Cancer: The Fukushima Health Management Survey.
Suzuki S; Nakamura I; Suzuki S; Ohkouchi C; Mizunuma H; Midorikawa S; Fukushima T; Ito Y; Shimura H; Ohira T; Matsuzuka T; Ohtsuru A; Abe M; Yamashita S; Suzuki S
Thyroid; 2016 May; 26(5):717-25. PubMed ID: 26971545
[TBL] [Abstract][Full Text] [Related]
30. The effect of thyroxine-suppressive therapy in patients with solitary non-toxic thyroid nodules -- a randomised, double-blind, placebo-controlled study.
Tsai CC; Pei D; Hung YJ; Wang TF; Tsai WC; Yao CY; Hsieh MC; Kuo SW
Int J Clin Pract; 2006 Jan; 60(1):23-6. PubMed ID: 16409424
[TBL] [Abstract][Full Text] [Related]
31. Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.
Baser H; Topaloglu O; Tam AA; Evranos B; Alkan A; Sungu N; Dumlu EG; Ersoy R; Cakir B
Endocrine; 2016 Aug; 53(2):520-9. PubMed ID: 26972701
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of thyroid nodule growth.
Quadbeck B; Pruellage J; Roggenbuck U; Hirche H; Janssen OE; Mann K; Hoermann R
Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):348-54. PubMed ID: 12397534
[TBL] [Abstract][Full Text] [Related]
33. Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial.
Blum MR; Gencer B; Adam L; Feller M; Collet TH; da Costa BR; Moutzouri E; Dopheide J; Depairon M; Sykiotis GP; Kearney P; Gussekloo J; Westendorp R; Stott DJ; Bauer DC; Rodondi N
J Clin Endocrinol Metab; 2018 Aug; 103(8):2988-2997. PubMed ID: 29846630
[TBL] [Abstract][Full Text] [Related]
34. Thyroxine suppressive therapy of benign solitary thyroid nodules: a prospective randomized study.
Cheung PS; Lee JM; Boey JH
World J Surg; 1989; 13(6):818-21; discussion 822. PubMed ID: 2696232
[TBL] [Abstract][Full Text] [Related]
35. Is percutaneous ethanol injection a useful alternative for the treatment of the cold benign thyroid nodule? Five years' experience.
Caraccio N; Goletti O; Lippolis PV; Casolaro A; Cavina E; Miccoli P; Monzani F
Thyroid; 1997 Oct; 7(5):699-704. PubMed ID: 9349572
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of suppressive therapy for cold thyroid nodules with levothyroxine: double-blind placebo-controlled clinical trial.
Larijani B; Pajouhi M; Bastanhagh MH; Sadjadi A; Sedighi N; Eshraghian MR
Endocr Pract; 1999; 5(5):251-6. PubMed ID: 15251662
[TBL] [Abstract][Full Text] [Related]
37. Benign thyroid nodules respond to a single administration of 0.3mg recombinant human thyrotropin with highly variable volume increase.
Bountouris P; Markantes GK; Mamali I; Markou KB; Michalaki MA
Front Endocrinol (Lausanne); 2022; 13():1066379. PubMed ID: 36714577
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials.
Sdano MT; Falciglia M; Welge JA; Steward DL
Otolaryngol Head Neck Surg; 2005 Sep; 133(3):391-6. PubMed ID: 16143188
[TBL] [Abstract][Full Text] [Related]
39. Relapse of Graves' disease after successful outcome of antithyroid drug therapy: results of a prospective randomized study on the use of levothyroxine.
Hoermann R; Quadbeck B; Roggenbuck U; Szabolcs I; Pfeilschifter J; Meng W; Reschke K; Hackenberg K; Dettmann J; Prehn B; Hirche H; Mann K;
Thyroid; 2002 Dec; 12(12):1119-28. PubMed ID: 12593726
[TBL] [Abstract][Full Text] [Related]
40. Role of cytological characteristics of benign thyroid nodules on effectiveness of their treatment with levothyroxine.
Cesur M; Akcil M; Ertek S; Emral R; Bulut S; Gullu S; Corapcioglu D
Arch Med Sci; 2013 Dec; 9(6):1083-9. PubMed ID: 24482654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
